Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy

• Maria Teresa Di Martino,
• Francesca Zazzeroni,
• Massimo Donadelli,
• Claudia Chiodoni,
• Michele Caraglia,
• Katia Scotlandi,
• Stefania Meschini,
• Carlo Leonetti

Affiliations

Maria Teresa Di Martino

Dept. of Experimental and Clinical Medicine, University of Catanzaro “Magna Graecia”

Francesca Zazzeroni

Dept. of Biotechnological and Applied Clinical Sciences, University of L’Aquila

Massimo Donadelli

Dept. of Neurosciences, Biomedicine and Movement Sciences, Section of Biochemistry, University of Verona

Claudia Chiodoni

Molecular Immunology Unit, Dept. of Research, Fondazione IRCCS Istituto Nazionale dei Tumori

Michele Caraglia

Department of Biochemistry, Biophysics and General Pathology, University of Campania “L. Vanvitelli”

Katia Scotlandi

Experimental Oncology Lab, CRS Development of Biomolecular Therapies, Orthopaedic Rizzoli Institute

Stefania Meschini

National Center for Drug Research and Evaluation, National Institute of Health

Carlo Leonetti

UOSD SAFU, Regina Elena National Cancer Institute